Inventor · disambiguated record
Xiangping Qian
Also filed as: QIAN XIANGPING · QIAN XIANGPING (SHAWN)
92 granted patents·30 pending applications·704 citations·filing 2002–2023
99Inventor score
Files withNEUPHARMA INC46CYTOKINETICS INC30QIAN XIANGPING22SUZHOU NEUPHARMA CO LTD10ASHCRAFT LUKE W5
Top patents by PatentIndex Score
122 records- 0198US11304957B2Substituted quinazolines for inhibiting kinase activityNEUPHARMA INC·Filed 2020·Granted Apr 19, 2022·4 cites·6 claims
- 0297US11865120B2Substituted quinazolines for inhibiting kinase activityNEUPHARMA INC·Filed 2022·Granted Jan 9, 2024·2 cites·14 claims
- 0397US10172868B2Substituted quinazolines for inhibiting kinase activityNEUPHARMA INC·Filed 2017·Granted Jan 8, 2019·10 cites·25 claims
- 0497US9849139B2Substituted quinazolines for inhibiting kinase activityNEUPHARMA INC·Filed 2016·Granted Dec 26, 2017·12 cites·40 claims
- 0597US9550770B2Substituted quinazolines for inhibiting kinase activityNEUPHARMA INC·Filed 2014·Granted Jan 24, 2017·15 cites·28 claims
- 0696US8101620B2Heterocyclic sulfonamidesMORGAN BRADLEY PAUL·Filed 2011·Granted Jan 24, 2012·40 cites·12 claims
- 0796US7888373B2Heterocyclic sulfonamides as modulators of cardiac sarcomeresCYTOKINETICS INC·Filed 2009·Granted Feb 15, 2011·40 cites·11 claims
- 0896US7504413B2N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseasesCYTOKINETICS INC·Filed 2005·Granted Mar 17, 2009·14 cites·96 claims
- 0995US10653701B2Substituted quinazolines for inhibiting kinase activityNEUPHARMA INC·Filed 2018·Granted May 19, 2020·7 cites·22 claims
- 1095US9730886B2Amino-pyrimidine skeletal muscle modulatorsCYTOKINETICS INC·Filed 2015·Granted Aug 15, 2017·17 cites·30 claims
- 1195US9604965B2Substituted pyridazines as skeletal muscle modulatorsCYTOKINETICS INC·Filed 2015·Granted Mar 28, 2017·20 cites·35 claims
- 1295US9572808B2Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancerNEUPHARMA INC·Filed 2015·Granted Feb 21, 2017·13 cites·11 claims
- 1395US9399659B2Certain chemical entities, compositions, and methodsSUZHOU NEUPHARMA CO LTD·Filed 2015·Granted Jul 26, 2016·12 cites·17 claims
- 1495US9249111B2Substituted quinoxalines as B-RAF kinase inhibitorsNEUPHARMA INC·Filed 2012·Granted Feb 2, 2016·13 cites·35 claims
- 1595US9133123B2Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their useASHCRAFT LUKE W·Filed 2011·Granted Sep 15, 2015·24 cites·45 claims
- 1695US8686007B2Certain heterocycles, compositions thereof, and methods for their useASHCRAFT LUKE W·Filed 2012·Granted Apr 1, 2014·15 cites·30 claims
- 1795US8334376B2Certain chemical entities, compositions, and methodsQIAN XIANGPING·Filed 2011·Granted Dec 18, 2012·19 cites·12 claims
- 1894US10765624B2Amino-pyrimidine skeletal muscle modulatorsCYTOKINETICS INC·Filed 2019·Granted Sep 8, 2020·5 cites·17 claims
- 1994US10076519B2Substituted pyridazines as skeletal muscle modulatorsCYTOKINETICS INC·Filed 2017·Granted Sep 18, 2018·16 cites·28 claims
- 2094US8993550B2Certain chemical entities, compositions, and methodsSUZHOU NEUPHARMA CO LTD·Filed 2012·Granted Mar 31, 2015·15 cites·10 claims
- 2193US9249110B2Substituted quinoxalines as B-raf kinase inhibitorsNEUPHARMA INC·Filed 2012·Granted Feb 2, 2016·13 cites·40 claims
- 2293US8969346B2Amino-pyridazine skeletal muscle modulatorsASHCRAFT LUKE W·Filed 2011·Granted Mar 3, 2015·23 cites·51 claims
- 2393US8759380B2Certain heterocycles, compositions thereof, and methods for their useASHCRAFT LUKE W·Filed 2012·Granted Jun 24, 2014·10 cites·44 claims
- 2493US7595322B2Heterocyclic sulfonamides as modulators of cardiac sarcomeresCYTOKINETICS INC·Filed 2004·Granted Sep 29, 2009·41 cites·10 claims
- 2593US7399866B2Compounds, compositions, and methodsCYTOKINETICS INC·Filed 2004·Granted Jul 15, 2008·29 cites·8 claims
- 2692US10947201B2Certain chemical entities, compositions, and methodsNEUPHARMA INC·Filed 2016·Granted Mar 16, 2021·6 cites·15 claims
- 2792US10179141B2Certain chemical entities, compositions, and methodsSUZHOU NEUPHARMA CO LTD·Filed 2017·Granted Jan 15, 2019·6 cites·18 claims
- 2892US9814735B2Certain chemical entities, compositions, and methodsSUZHOU NEUPHARMA CO LTD·Filed 2016·Granted Nov 14, 2017·7 cites·24 claims
- 2992US9018197B2Tetradecahydro-1H-cyclopenta[a]phenanthrene compounds, compositions, and related methods of useQIAN XIANGPING·Filed 2011·Granted Apr 28, 2015·9 cites·48 claims
- 3092US8088793B2Certain chemical entities, compositions, and methodsQIAN XIANGPING·Filed 2008·Granted Jan 3, 2012·20 cites·74 claims
- 3192US7491826B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2004·Granted Feb 17, 2009·27 cites·8 claims
- 3291US10272030B2Amino-pyrimidine skeletal muscle modulatorsCYTOKINETICS INC·Filed 2017·Granted Apr 30, 2019·6 cites·8 claims
- 3391US9518029B2Certain chemical entities, compositions, and methodsQIAN XIANGPING·Filed 2012·Granted Dec 13, 2016·10 cites·33 claims
- 3491US9340570B2Certain chemical entities, compositions, and methodsQIAN XIANGPING·Filed 2013·Granted May 17, 2016·12 cites·37 claims
- 3591US9278962B2Certain heterocycles, compositions thereof, and methods for their useASHCRAFT LUKE W·Filed 2014·Granted Mar 8, 2016·7 cites·33 claims
- 3691US8962632B2Certain amino-pyrimidines, compositions thereof, and methods for their useYANG ZHE·Filed 2011·Granted Feb 24, 2015·15 cites·63 claims
- 3791US7582668B2Imidazoyl-benzamide anti-cancer agentsCYTOKINETICS INC·Filed 2006·Granted Sep 1, 2009·5 cites·6 claims
- 3890US12403145B2Substituted quinazolines for inhibiting kinase activityNEUPHARMA INC·Filed 2023·Granted Sep 2, 2025·0 cites·20 claims
- 3990US10544106B2Certain chemical entities, compositions, and methodsNEUPHARMA INC·Filed 2017·Granted Jan 28, 2020·7 cites·27 claims
- 4090US10065986B2Certain chemical entities, compositions, and methodsNEUPHARMA INC·Filed 2016·Granted Sep 4, 2018·6 cites·14 claims
- 4190US9493503B2Certain chemical entities, compositions, and methodsQIAN XIANGPING·Filed 2012·Granted Nov 15, 2016·10 cites·17 claims
- 4289US9994528B2Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their useCYTOKINETICS INC·Filed 2015·Granted Jun 12, 2018·5 cites·34 claims
- 4389US9688635B2Certain chemical entities, compositions, and methodsNEUPHARMA INC·Filed 2013·Granted Jun 27, 2017·10 cites·23 claims
- 4489US9676813B2Certain steroids and methods for using the same in the treatment of cancerNEUPHARMA INC·Filed 2013·Granted Jun 13, 2017·9 cites·20 claims
- 4589US9295671B2Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancerZHU YONG-LIANG·Filed 2012·Granted Mar 29, 2016·14 cites·24 claims
- 4688US9670180B2Certain chemical entities, compositions, and methodsNEUPHARMA INC·Filed 2013·Granted Jun 6, 2017·9 cites·53 claims
- 4787US11208388B2Certain chemical entities, compositions, and methodsNEUPHARMA INC·Filed 2019·Granted Dec 28, 2021·2 cites·17 claims
- 4886US11369565B2Amino-pyrimidine skeletal muscle modulatorsCYTOKINETICS INC·Filed 2020·Granted Jun 28, 2022·1 cites·19 claims
- 4986US10065932B2Certain chemical entities, compositions, and methodsNEUPHARMA INC·Filed 2017·Granted Sep 4, 2018·3 cites·22 claims
- 5086US9908866B2Certain chemical entities, compositions, and methodsNEUPHARMA INC·Filed 2017·Granted Mar 6, 2018·5 cites·23 claims
Showing the top 50 of 122 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Xiangping Qian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →